Sylvia Nikkho

Inhaled Iloprost for Severe Pulmonary Hypertension

Horst Olschewski, Gérald Simonneau, Nazzareno Galiè et al. · New England Journal of Medicine · 2002 · 1.8K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +12

Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trial

Gérald Simonneau, Andrea Maria D’Armini, Friedrich Grimminger et al. · The Lancet Respiratory Medicine · 2016 · 152 citations

Medicine, Internal Medicine, Pharmacotherapy +9

Predictors of long-term outcomes in patients treated with riociguat for pulmonary arterial hypertension: data from the PATENT-2 open-label, randomised, long-term extension trial

Friedrich Grimminger, Ekkehard Grünig, Yigao Huang et al. · The Lancet Respiratory Medicine · 2016 · 122 citations · Full text

Medicine, Cardiology, Pharmacology +10

Long-term therapy with inhaled iloprost in patients with pulmonary hypertension

Horst Olschewski, Marius M. Hoeper, Ralf Ewert et al. · Respiratory Medicine · 2010 · 79 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +12

REVEAL risk score in patients with chronic thromboembolic pulmonary hypertension receiving riociguat

Raymond L. Benza, Harrison W. Farber, Adaani Frost et al. · The Journal of Heart and Lung Transplantation · 2018 · 47 citations · Full text

Medicine, Cardiology, Pharmacotherapy +11